Swanson-Biearman B, Krenzelok EP. 2001. Delayed life-threatening reaction to anthrax vaccine. Journal of Toxicology. Clinical Toxicology 39(1):81–84.

Tanner J. 2001. Survey results of the 9th Airlift Squadron. Presentation to the Joint Meeting of the Institute of Medicine Committee to Assess the Safety and Efficacy of the Anthrax Vaccine and the Institute of Medicine Committee to Review the CDC Anthrax Vaccine Safety and Efficacy Research Program, Meeting III, Washington, D.C.

Tilson H. 1992. Pharmacosurveillance: public health monitoring of medication. In: Halperin W, Baker EL, Monson RR (consulting ed.), eds. Public Health Surveillance. New York, N.Y.: Van Nostrand Reinhold. Pp. 206–229.

U.S. Congress, House of Representatives, Committee on Government Reform. 2000. The Department of Defense Anthrax Vaccine Immunization Program: Unproven Force Protection. House Report 106-556. Washington, D.C.: U.S. House of Representatives.

VAERS (Vaccine Adverse Event Reporting System). 2001. A federal program for surveillance of vaccine safety. Brochure. Vaccine Adverse Event Reporting System, Rockville, Md.

Weibel R. 2001. Charge or mission statement for AVEC. E-mail to Joellenbeck L, Institute of Medicine, Washington, D.C., May 16.

The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement